doi:10.48130/newcontam-0026-0012

[1]

Starling MCVM, Amorim CC, Leão MMD. 2019. Occurrence, control and fate of contaminants of emerging concern in environmental compartments in Brazil. Journal of Hazardous Materials 372:17−36

doi: 10.1016/j.jhazmat.2018.04.043

[2]

Fontes MK, Gusso-Choueri PK, Maranho LA, de Souza Abessa DM, Almeida Mazur W, et al. 2018. A tiered approach to assess effects of diclofenac on the brown mussel Perna perna: a contribution to characterize the hazard. Water Research 132:361−370

doi: 10.1016/j.watres.2017.12.077

[3]

Maranho LA, dos Santos DM, da Fonseca TG, dos Santos Barbosa Ortega A, da Silva Sousa L, et al. 2021. Occurrence and environmental fate of pharmaceuticals, personal care products and illicit drugs (PPCPIDs) in tropical ecosystems. In Pharmaceuticals in Marine and Coastal Environments: Occurrence, Effects and Challenges in a Changing World, eds. Durán-Álvarez JC, Jiménez-Cisneros B. Amsterdam: Elsevier. pp. 169−193 doi: 10.1016/B978-0-08-102971-8.00001-9

[4]

Spongberg AL, Witter JD, Acuña J, Vargas J, Murillo M, et al. 2011. Reconnaissance of selected PPCP compounds in Costa Rican surface waters. Water Research 45:6709−6717

doi: 10.1016/j.watres.2011.10.004

[5]

Fang TH, Nan FH, Chin TS, Feng HM. 2021. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters. Marine Pollution Bulletin 64:1435−1444

doi: 10.1016/j.marpolbul.2012.04.008

[6]

Bayen S, Zhang H, Desai MM, Ooi SK, Kelly BC. 2013. Occurrence and distribution of pharmaceutically active and endocrine disrupting compounds in Singapore's marine environment: influence of hydrodynamics and physical chemical properties. Environmental Pollution 182:1−8

doi: 10.1016/j.envpol.2013.06.028

[7]

Omar TFT, Aris AZ, Yusoff FM, Mustafa S. 2019. Risk assessment of pharmaceutically active compounds (PhACs) in the Klang River estuary, Malaysia. Environmental Geochemistry and Health 41:211−223

doi: 10.1007/s10653-018-0157-1

[8]

Guruge KS, Goswami P, Tanoue R, Nomiyama K, Wijesekara RGS, et al. 2019. First nationwide investigation and environmental risk assessment of 72 pharmaceuticals and personal care products from Sri Lankan surface waterways. Science of The Total Environment 690:683−695

doi: 10.1016/j.scitotenv.2019.07.042

[9]

Beretta M, Britto V, Tavares TM, da Silva SMT, Pletsch. AL. 2014. Occurrence of pharmaceutical and personal care products (PPCPs) in marine sediments in the Todos os Santos Bay and the north coast of Salvador, Bahia, Brazil. Journal of Soils and Sediments 14:1278−1286

doi: 10.1007/s11368-014-0884-6

[10]

Pereira CDS, Maranho LA, Cortez FS, Pusceddu FH, Santos AR, et al. 2016. Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone. Science of The Total Environment 548:148−154

doi: 10.1016/j.scitotenv.2016.01.051

[11]

Moreira RDS. 2020. COVID-19: intensive care units, mechanical ventilators, and latent mortality profiles associated with case-fatality in Brazil. Cadernos de Saúde Pública 36(5):e00080020

doi: 10.1590/0102-311x00080020

[12]

Souza MNC, Ricardino IEF, Sampaio K, Silva MR, de Lima APG, et al. 2021. Occurrence of self-medication in the Brazilian population as a preventive strategy for SARS-CoV-2. Research, Society and Development 10(1):e44510111933

doi: 10.33448/rsd-v10i1.11933

[13]

COVID-19 Treatment Guidelines Panel. 2019. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. www.ncbi.nlm.nih.gov/books/NBK570371/pdf/Bookshelf_NBK570371.pdf

[14]

Farias DF, Souza T, Souza JACR, Vieira LR, Muniz MS, et al. 2020. COVID-19 therapies in Brazil: should we be concerned with the impacts on aquatic wildlife? Environmental Toxicology and Chemistry 39(12):2348−2350

doi: 10.1002/etc.4888

[15]

Goulart AH, Muñoz IK. 2020. Disinformation and post-truth in the context of the Covid-19 pandemic: a study of information practices on Facebook. Liinc em Revista 16(2):e5397

doi: 10.18617/liinc.v16i2.5397

[16]

Tanni SE, Bacha HA, Naime A, Bernardo WM. 2021. Use of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: a systematic review and meta-analysis. Jornal Brasileiro de Pneumologia 47(5):e20210236

doi: 10.36416/1806-3756/e20210236

[17]

da Costa Gomes J, da Silva JCA, Batalha SSA. 2021. Occurrence of self-medication in the COVID-19 pandemic: an integrative literature review. Research, Society and Development 10(16):e308101624049

doi: 10.33448/rsd-v10i16.24049

[18]

Iesce MR, Lavorgna M, Russo C, Piscitelli C, Passananti M, et al. 2019. Ecotoxic effects of loratadine and its metabolic and light-induced derivatives. Ecotoxicology and Environmental Safety 170:664−672

doi: 10.1016/j.ecoenv.2018.11.116

[19]

Kristofco LA, Brooks BW. 2017. Global scanning of antihistamines in the environment: analysis of occurrence and hazards in aquatic systems. Science of The Total Environment 592:477−487

doi: 10.1016/j.scitotenv.2017.03.120

[20]

Vestel JS, Hong JY, Meng Q, Naumann BD, Robson MG, et al. 2017. The endocrine disruption potential of betamethasone using Japanese medaka as a fish model. Human and Ecological Risk Assessment: An International Journal 23(4):879−894

doi: 10.1080/10807039.2017.1292841

[21]

DellaGreca M, Fiorentino A, Isidori M, Lavorgna M, Previtera L, et al. 2004. Toxicity of prednisolone, dexamethasone and their photochemical derivatives on aquatic organisms. Chemosphere 54(5):629−637

doi: 10.1016/j.chemosphere.2003.09.008

[22]

Bal N, Kumar A, Du J, Nugegoda D. 2017. Multigenerational effects of two glucocorticoids (prednisolone and dexamethasone) on life-history parameters of crustacean Ceriodaphnia dubia (Cladocera). Environmental Pollution 225:569−578

doi: 10.1016/j.envpol.2017.03.024

[23]

LaLone CA, Villeneuve DL, Olmstead AW, Medlock EK, Kahl MD, et al. 2012. Effects of a glucocorticoid receptor agonist, dexamethasone, on fathead minnow reproduction, growth, and development. Environmental Toxicology and Chemistry 31(3):611−622

doi: 10.1002/etc.1729

[24]

Cuzziol Boccioni AP, Peltzer PM, Martinuzzi CS, Attademo AM, León EJ, et al. 2021. Morphological and histological abnormalities of the neotropical toad, Rhinella arenarum (Anura: Bufonidae) larvae exposed to dexamethasone. Journal of Environmental Science and Health, Part B 56(1):41−53

doi: 10.1080/03601234.2020.1832410

[25]

Kugathas S, Sumpter JP. 2011. Synthetic glucocorticoids in the environment: first results on their potential impacts on fish. Environmental Science & Technology 45:2377−2383

doi: 10.1021/es104105e

[26]

Domínguez-García P, Rodríguez RR, Barata C, Gómez-Canela C. 2023. Presence and toxicity of drugs used to treat SARS-CoV-2 in Llobregat River, Catalonia, Spain. Environmental Science and Pollution Research 30:49487−49497

doi: 10.1007/s11356-023-25512-9

[27]

Stokkermans TJ, Falkowitz DM, Trichonas G. 2025. Chloroquine and Hydroxychloroquine Toxicity. Treasure Island (FL): StatPearls Publishing. www.ncbi.nlm.nih.gov/books/NBK537086/ (accessed on May 2, 2025)

[28]

Dabić D, Babić S, Škorić I. 2019. The role of the photodegradation in the environmental fate of hydroxychloroquine. Chemosphere 230:268−277

doi: 10.1016/j.chemosphere.2019.05.032

[29]

dos Reis Neto ET, Kakehasi AM, de Medeiros Pinheiro M, Ferreira GA, Marques CDL, et al. 2020. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Advances in Rheumatology 60:32

doi: 10.1186/s42358-020-00134-8

[30]

Ramesh M, Anitha S, Poopal RK, Shobana C. 2018. Evaluation of acute and sublethal effects of chloroquine (C₁₈H₂₆CIN₃) on certain enzymological and histopathological biomarker responses of a freshwater fish Cyprinus carpio. Toxicology Reports 5:18−27

doi: 10.1016/j.toxrep.2017.11.006

[31]

Zurita JL, Jos Á, del Peso A, Salguero M, López-Artíguez M, et al. 2005. Ecotoxicological evaluation of the antimalarial drug chloroquine. Aquatic Toxicology 75:97−107

doi: 10.1016/j.aquatox.2005.07.009

[32]

Arce-Fonseca M, Gutiérrez-Ocejo RA, Rosales-Encina JL, Aranda-Fraustro A, Cabrera-Mata JJ, et al. 2023. Nitazoxanide: a drug repositioning compound with potential use in Chagas disease in a murine model. Pharmaceuticals 16(6):826

doi: 10.3390/ph16060826

[33]

Vignoles P, Dreyfuss G, Rondelaud D. 1996. Growth modification of Euglena gracilis Klebs after 2-benzamido-5-nitrothiazole derivatives application. Ecotoxicology and Environmental Safety 34(2):118−124

doi: 10.1006/eesa.1996.0052

[34]

Lu W, Yang F, Meng Y, An J, Hu B, et al. 2023. Immunotoxicity and transcriptome analysis of zebrafish embryos exposure to nitazoxanide. Fish & Shellfish Immunology 141:108977

doi: 10.1016/j.fsi.2023.108977

[35]

Grant A, Briggs AD. 1998. Toxicity of ivermectin to estuarine and marine invertebrates. Marine Pollution Bulletin 36(7):540−541

doi: 10.1016/S0025-326X(98)00012-5

[36]

Halley BA, Jacob TA, Lu AYH. 1989. The environmental impact of the use of ivermectin: environmental effects and fate. Chemosphere 18(7−8):1543−1563

doi: 10.1016/0045-6535(89)90045-3

[37]

Sanderson H, Laird B, Pope L, Brain R, Wilson C, et al. 2007. Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms. Aquatic Toxicology 85(4):229−240

doi: 10.1016/j.aquatox.2007.08.011

[38]

Carlsson G, Patring J, Kreuger J, Norrgren L, Oskarsson A. 2013. Toxicity of 15 veterinary pharmaceuticals in zebrafish (Danio rerio) embryos. Aquatic Toxicology 126:30−41

doi: 10.1016/j.aquatox.2012.10.008

[39]

Garric J, Vollat B, Duis K, Péry A, Junker T, et al. 2007. Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata. Chemosphere 69:903−910

doi: 10.1016/j.chemosphere.2007.05.070

[40]

Gerhardt A. 2009. Screening the toxicity of Ni, Cd, Cu, Ivermectin, and Imidacloprid in a short-term automated behavioral toxicity test with Tubifex tubifex (Müller 1774) (Oligochaeta). Human and Ecological Risk Assessment 15(1):27−40

doi: 10.1080/10807030802614983

[41]

Escher BI, Berger C, Bramaz N, Kwon JH, Richter M, et al. 2008. Membrane–water partitioning, membrane permeability, and baseline toxicity of the parasiticides ivermectin, albendazole, and morantel. Environmental Toxicology and Chemistry 27(4):909−918

doi: 10.1897/07-427.1

[42]

Lopes C, Charles S, Vollat B, Garric J. 2009. Toxicity of ivermectin on cladocerans: comparison of toxic effects on Daphnia and Ceriodaphnia species. Environmental Toxicology and Chemistry 28(10):2160−2166

doi: 10.1897/08-607.1

[43]

Davies IM, McHenery JG, Rae GH. 1997. Environmental risk from dissolved ivermectin to marine organisms. Aquaculture 158:263−275

doi: 10.1016/S0044-8486(97)00209-3

[44]

Associação Brasileira de Normas Técnicas (ABNT). 2016. Ecotoxicologia aquática - Toxicidade aguda - Método de ensaio com Artemia sp. (Crustacea, Brachiopoda) [Aquatic ecotoxicology - Acute toxicity - Test method with Artemia sp. (Crustacea, Brachiopoda)]. ABNT NBR 16530. ABNT, Rio de Janeiro, Brazil. www.target.com.br/produtos/normas-tecnicas/44088/nbr16530-ecotoxicologia-aquatica-toxicidade-aguda-metodo-de-ensaio-com-artemia-sp-crustacea-brachiopoda (accessed on April 9, 2026)

[45]

Veiga LF, Vital N. 2002. Teste de toxicidade aguda com o microcrustáceo Artemia sp. In Métodos em Ecotoxicologia Marinha: Aplicações no Brasil. eds. Nascimento IA, Souza ECPM, Nipper M. Vol. 1. São Paulo, SP, Brasil: Editora Artes Gráficas e Indústria Ltda. pp. 111−122

[46]

World Health Organization (WHO). 2025. WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/cases (accessed on May 7, 2025)

[47]

Gwenzi W, Selvasembian R, Offiong NO, El Din Mahmoud A, Sanganyado E, et al. 2022. COVID-19 drugs in aquatic systems: a review. Environmental Chemistry Letters 20(2):1275−1294

doi: 10.1007/s10311-021-01356-y

[48]

Kuroda K, Li C, Dhangar K, Kumar M. 2021. Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters. Science of The Total Environment 776:145740

doi: 10.1016/j.scitotenv.2021.145740

[49]

Vaduganathan M, van Meijgaard J, Mehra MR, Joseph J, O'Donnell CJ, et al. 2020. Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States. JAMA 323:2524−2526

doi: 10.1001/jama.2020.9184

[50]

Nippes RP, Macruz PD, da Silva GN, Neves Olsen Scaliante MH. 2021. A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment. Process Safety and Environmental Protection 152:568−582

doi: 10.1016/j.psep.2021.06.040

[51]

Chen WY, Lin CJ, Liao CM. 2014. Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions. Environmental Pollution 184:377−384

doi: 10.1016/j.envpol.2013.09.019

[52]

Morales-Paredes CA, Rodríguez-Díaz JM, Boluda-Botella N. 2022. Pharmaceutical compounds used in the COVID-19 pandemic: a review of their presence in water and treatment techniques for their elimination. Science of The Total Environment 814:152691

doi: 10.1016/j.scitotenv.2021.152691

[53]

Kumar R, Sharma A, Srivastava JK, Siddiqui MH, Uddin MS, et al. 2021. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications. Environmental Science and Pollution Research 28:40431−40444

doi: 10.1007/s11356-020-12200-1

[54]

Cappelli F, Longoni O, Rigato J, Rusconi M, Sala A, et al. 2022. Suspect screening of wastewaters to trace anti-COVID-19 drugs: potential adverse effects on aquatic environment. Science of The Total Environment 824:153756

doi: 10.1016/j.scitotenv.2022.153756

[55]

Domingo-Echaburu S, Irazola M, Prieto A, Rocano B, Lopez de Torre-Querejazu A, et al. 2022. Drugs used during the COVID-19 first wave in Vitoria-Gasteiz (Spain) and their presence in the environment. Science of The Total Environment 820:153122

doi: 10.1016/j.scitotenv.2022.153122

[56]

Ferreira MT, dos Santos Carvalho C. 2023. Chloroquine and hydroxychloroquine in the environment and aquatic organisms: a review. Ambiente e Agua − an Interdisciplinary Journal of Applied Science 18:e2880

doi: 10.4136/ambi-agua.2880

[57]

Ben Ali M, Hedfi A, Almalki M, Karachle PK, Boufahja F. 2021. Toxicity of hydroxychloroquine, a potential treatment for COVID-19, on free-living marine nematodes. Marine Pollution Bulletin 167:112361

doi: 10.1016/j.marpolbul.2021.112361

[58]

Sanches-Neto FO, Coutinho ND, Aquilanti V, Silva WA, Carvalho-Silva VH. 2023. Mechanism and kinetics of the degradation of nitazoxanide and hydroxychloroquine drugs by hydroxyl radicals: theoretical approach to ecotoxicity. Journal of the Brazilian Chemical Society 34(8):1119−1129

doi: 10.21577/0103-5053.20230025

[59]

Khan K, Kar S, Roy K. 2023. Are we ready to combat the ecotoxicity of COVID-19 pharmaceuticals? An in silico aquatic risk assessment. Aquatic Toxicology 256:106416

doi: 10.1016/j.aquatox.2023.106416

[60]

Löffler D, Römbke J, Meller M, Ternes TA. 2005. Environmental fate of pharmaceuticals in water/sediment systems. Environmental Science & Technology 39:5209−5218

doi: 10.1021/es0484146

[61]

Essid N, Allouche M, Lazzem M, Harrath AH, Mansour L, et al. 2020. Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment. Marine Pollution Bulletin 157:111375

doi: 10.1016/j.marpolbul.2020.111375

[62]

Prasse C, Löffler D, Ternes TA. 2009. Environmental fate of the anthelmintic ivermectin in an aerobic sediment/water system. Chemosphere 77:1321−1325

doi: 10.1016/j.chemosphere.2009.09.045

[63]

Tarazona JV, Martínez M, Martínez MA, Anadón A. 2021. Environmental impact assessment of COVID-19 therapeutic solutions. A prospective analysis. Science of The Total Environment 778:146257

doi: 10.1016/j.scitotenv.2021.146257

[64]

Juarez M, Schcolnik-Cabrera A, Dueñas-Gonzalez A. 2018. The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. American Journal of Cancer Research 8:317−331

[65]

Martin RJ, Robertson AP, Choudhary S. 2021. Ivermectin: an anthelmintic, an insecticide, and much more. Trends in Parasitology, 37(1):48−64

doi: 10.1016/j.pt.2020.10.005

[66]

Blizzard TA, Ruby CL, Mrozik H, Preiser FA, Fisher MH. 1989. Brine shrimp (Artemia salina) as a convenient bioassay for avermectin analogs. The Journal of Antibiotics 42(8):1304−1307

doi: 10.7164/antibiotics.42.1304

[67]

Ignoto S, Pecoraro R, Scalisi EM, Buttigè SE, Contino M, et al. 2022. Acute toxicity of a marine emerging pollutant (promethazine hydrochloride) on Artemia sp. ACS Omega 7(44):39619−39623

doi: 10.1021/acsomega.2c00856

[68]

Macikova P, Groh KJ, Ammann AA, Schirmer K, Suter MJ. 2014. Endocrine disrupting compounds affecting corticosteroid signaling pathways in Czech and Swiss waters: potential impact on fish. Environmental Science & Technology 48:12902−12911

doi: 10.1021/es502711c

[69]

Zhang H, Sun J, Wang W, Yu J. 2011. Brine shrimp diversity in China based on DNA barcoding. In Changing Diversity in Changing Environment. eds. Grillo O, Venora G. London, UK: IntechOpen. pp. 243−258 doi: 10.5772/24975

[70]

O’Flynn D, Lawler J, Yusuf A, Parle-McDermott A, Harold D, et al. 2021. A review of pharmaceutical occurrence and pathways in the aquatic environment in the context of a changing climate and the COVID-19 pandemic. Analytical Methods 13:575−594

doi: 10.1039/D0AY02098B